BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -50.15%122.36M | 6.77%987.26M | 32.34%690.61M | --476.18M | --245.42M | 47.08%924.67M | --521.84M | 62.51%628.69M | --258.47M | -4.87%386.87M |
Refunds of taxes and levies | 7.09%5.04M | -54.99%10.81M | -36.78%9.19M | --7.44M | --4.7M | -24.96%24.01M | --14.53M | 283.50%32M | --11.92M | 28.08%8.34M |
Cash received relating to other operating activities | 62.57%27.25M | -74.18%18.82M | -73.87%17.43M | --10.78M | --16.76M | 9.42%72.9M | --66.7M | 248.90%66.62M | --63.85M | -80.04%19.09M |
Cash inflows from operating activities | -42.06%154.65M | -0.46%1.02B | 18.93%717.23M | --494.4M | --266.89M | 40.46%1.02B | --603.06M | 75.55%727.31M | --334.25M | -18.58%414.31M |
Goods services cash paid | -36.82%79.44M | 4.72%532.85M | 11.22%387.58M | --259.08M | --125.74M | 18.51%508.83M | --348.49M | 76.79%429.35M | --174.25M | 14.01%242.85M |
Staff behalf paid | 15.45%42.04M | 15.37%88.11M | 20.46%72.29M | --52.79M | --36.41M | 26.06%76.37M | --60.01M | 5.33%60.58M | --37.19M | 25.77%57.52M |
All taxes paid | -24.86%22.48M | 57.26%93.04M | 54.46%70.7M | --50.62M | --29.92M | 128.95%59.16M | --45.77M | -30.21%25.84M | --8.39M | 21.64%37.02M |
Cash paid relating to other operating activities | 256.40%43M | 68.13%63.43M | 58.06%33.81M | --15.02M | --12.06M | -53.80%37.72M | --21.39M | -21.98%81.66M | --63.65M | 272.26%104.66M |
Cash outflows from operating activities | -8.42%186.95M | 13.98%777.42M | 18.65%564.37M | --377.52M | --204.13M | 14.17%682.08M | --475.65M | 35.15%597.43M | --283.48M | 39.32%442.05M |
Net cash flows from operating activities | -151.47%-32.3M | -29.46%239.47M | 19.97%152.86M | --116.89M | --62.76M | 161.39%339.5M | --127.41M | 568.12%129.88M | --50.77M | -114.48%-27.74M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.4M | ---- | ---- |
Cash received from returns on investments | 1,840.88%640.58K | 20.65%3.95M | 25.76%3.95M | --3.63M | --33K | -55.93%3.27M | --3.14M | --7.43M | --1.24M | ---- |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 233.89%123.89K | 300.00%123.89K | --123.89K | ---- | 3,310.50%37.11K | --30.97K | -99.74%1.09K | --1.09K | -96.46%422K |
Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10M | --10M | ---- |
Cash inflows from investing activities | 1,840.88%640.58K | 23.04%4.07M | 28.44%4.07M | --3.75M | --33K | -86.10%3.31M | --3.17M | 5,547.42%23.83M | --11.24M | -97.62%422K |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 33.04%12.56M | 52.83%54.53M | 81.16%45.45M | --34.99M | --9.44M | -18.43%35.68M | --25.09M | 44.07%43.74M | --5.4M | 0.58%30.36M |
Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6M |
Cash paid relating to other investing activities | 416.92%445.27M | 81.20%209.05M | 76.70%175.28M | --135.28M | --86.14M | --115.37M | --99.19M | ---- | ---- | 50.00%30M |
Cash outflows from investing activities | 379.01%457.83M | 74.50%263.57M | 77.60%220.73M | --170.27M | --95.58M | 245.34%151.05M | --124.28M | -34.09%43.74M | --5.4M | 32.23%66.36M |
Net cash flows from investing activities | -378.51%-457.19M | -75.65%-259.5M | -78.89%-216.65M | ---166.52M | ---95.54M | -642.15%-147.73M | ---121.11M | 69.81%-19.91M | --5.84M | -103.37%-65.94M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --381.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from borrowing | ---- | ---- | ---- | ---- | ---- | --24M | --24M | ---- | ---- | ---- |
Cash inflows from financing activities | --381.38M | ---- | ---- | ---- | ---- | --24M | --24M | ---- | ---- | ---- |
Borrowing repayment | ---- | --24M | --24M | --24M | ---- | ---- | ---- | --24M | ---- | ---- |
Dividend interest payment | ---- | -99.46%299K | -99.46%299K | --299K | --209.3K | 6,011.29%55.83M | --55.62M | -91.74%913.5K | --527.8K | -93.34%11.06M |
Cash outflows from financing activities | ---- | -56.47%24.3M | -56.31%24.3M | --24.3M | --209.3K | 124.08%55.83M | --55.62M | 125.29%24.91M | --527.8K | -94.18%11.06M |
Net cash flows from financing activities | 182,317.47%381.38M | 23.65%-24.3M | 23.15%-24.3M | ---24.3M | ---209.3K | -27.75%-31.83M | ---31.62M | -125.29%-24.91M | ---527.8K | 88.41%-11.06M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 1,920.64%1.07M | -379.65%-1.69M | 4.34%-286.67K | ---1.05M | ---58.85K | -80.68%604.97K | ---299.68K | 132.24%3.13M | ---3.16M | -608.53%-9.71M |
Net increase in cash and cash equivalents | -223.86%-107.04M | -128.66%-46.02M | -245.06%-88.38M | ---74.98M | ---33.05M | 82.04%160.54M | ---25.61M | 177.05%88.19M | --52.92M | -274.40%-114.46M |
Add:Begin period cash and cash equivalents | -15.60%248.94M | 119.43%294.96M | 119.43%294.96M | --294.96M | --294.96M | 190.78%134.42M | --134.42M | -71.23%46.23M | --46.23M | 69.04%160.68M |
End period cash equivalent | -45.82%141.9M | -15.60%248.94M | 89.86%206.58M | --219.98M | --261.91M | 119.43%294.96M | --108.8M | 190.78%134.42M | --99.15M | -71.23%46.23M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | Unqualified opinion | -- | Unqualified opinion |
Auditor | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | ZTE Accounting firm (Special General Partnership) | -- | ZTE Accounting firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.